Cargando…
Carnitine Orotate Complex Ameliorates Insulin Resistance and Hepatic Steatosis Through Carnitine Acetyltransferase Pathway
BACKGROUND: Carnitine orotate complex (Godex) has been shown to decrease glycated hemoglobin levels and improve steatosis in patients with type 2 diabetes mellitus with non-alcoholic fatty liver disease. However, the mechanisms of Godex in glucose metabolism remain unclear. METHODS: Male C57BL/6J mi...
Autores principales: | Hong, Jung-Hee, Lee, Moon-Kyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Diabetes Association
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8640142/ https://www.ncbi.nlm.nih.gov/pubmed/34407600 http://dx.doi.org/10.4093/dmj.2020.0223 |
Ejemplares similares
-
The Role of Carnitine Orotate Complex in Fatty Liver
por: Yi, Hyon-Seung
Publicado: (2021) -
Carnitine acetyltransferase: A new player in skeletal muscle insulin resistance?
por: Berg, Sofia Mikkelsen, et al.
Publicado: (2016) -
Prolonged Use of Carnitine-Orotate Complex (Godex(®)) Is Associated with Improved Mortality: A Nationwide Cohort Study
por: Park, Kye-Yeung, et al.
Publicado: (2022) -
Kinetics of the Solution-Mediated Polymorphic Transformation of the Novel l-Carnitine Orotate Polymorph, Form-II
por: An, Ji-Hun, et al.
Publicado: (2018) -
l-Carnitine counteracts in vitro fructose-induced hepatic steatosis through targeting oxidative stress markers
por: Montesano, A., et al.
Publicado: (2019)